April 14, 2014
The Ministry of Health, Labor and Welfare’s (MHLW) panel of experts finalized on April 11 an investigative report on a clinical trial scandal involving Novartis Pharma’s top-selling blood pressure drug Diovan (valsartan) after tweaking some of its wording. No major...read more